Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

192 trials

NCT07711418
Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Phase 3 · Austria, Czechia, Germany, Croatia, Hungary, Italy, Latvia, Poland, Portugal, United States · 83 sites
Registry update: 8 Sept 2026
NCT07598058
Recruiting
PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry
Not applicable · United States · 1 site
Registry update: 26 Aug 2026
NCT07560618
Recruiting
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Phase 4 · United States · 1 site
Registry update: 13 Aug 2026
NCT07487831
Recruiting
The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Phase 4 · United States · 2 sites
Registry update: 9 Sept 2026
NCT07660835
Recruiting
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis
Phase 2 · Poland, United States · 8 sites
Registry update: 14 Aug 2026
NCT07754968
Recruiting
Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic Dermatitis
Not applicable · Italy · 1 site
Registry update: 10 Aug 2026
NCT07690371
Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Phase 3 · Belgium, Bulgaria, Czechia, Germany, Spain, Greece, Lithuania, Poland, Slovakia, United States · 87 sites
Registry update: 21 Oct 2026
NCT07643766
Recruiting
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · United States · 9 sites
Registry update: 6 Aug 2026
NCT07660731
Recruiting
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Phase 1 · Belgium, United States · 2 sites
Registry update: 3 Nov 2026
NCT07730788
Recruiting
Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab
Not applicable · France · 1 site
Registry update: 28 Jul 2026
NCT07645820
Recruiting
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Not applicable · United States · 16 sites
Registry update: 9 Nov 2026
NCT07544862
Recruiting
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
Not applicable · China · 1 site
Registry update: 10 Jun 2026
NCT07604324
Recruiting
A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis
Phase 1 · Japan · 1 site
Registry update: 19 Aug 2026
NCT07455578
Recruiting
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Phase 1 · Australia · 2 sites
Registry update: 1 Jun 2026
NCT07598383
Recruiting
A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
Phase 2 · China · 1 site
Registry update: 7 Jul 2026
NCT07599813
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Bulgaria, Canada, Czechia, Germany, Spain, Hungary, Poland, United States · 85 sites
Registry update: 28 Aug 2026
NCT07629778
Recruiting
HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
Phase 1/2 · China · 1 site
Registry update: 23 Jun 2026
NCT07527923
Recruiting
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Phase 1 · Belgium, United States · 9 sites
Registry update: 6 Nov 2026
NCT07693738
Recruiting
A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
Phase 1 · China · 1 site
Registry update: 10 Jul 2026
NCT07592585
Recruiting
Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis
Phase 3 · China · 1 site
Registry update: 7 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.